LY-294,002 hydrochloride, 98%, selective inhibitor of PI 3-kinase

Name: LY-294,002 hydrochloride, 98%, selective inhibitor of PI 3-kinase | 934389-88-5
Brand: J&K Chemical
SKU: JK1093593_25_MG
Price: 323.0 USD
Availability: OutOfStock

Cat. No JK1093593_25_MG

Vendor: J&K Chemical

Product Information

Product Name

LY-294,002 hydrochloride, 98%, selective inhibitor of PI 3-kinase

Brand Name

J&K

Product Number

1093593

CAS

934389-88-5

Molecular Formula

C19H17NO3·HCl

Molecular Weight

343.81

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

11957589

IUPAC Name

2-morpholin-4-yl-8-phenylchromen-4-one;hydrochloride

InChI Key

OQZQSRICUOWBLW-UHFFFAOYSA-N

SMILES

C1COCCN1C2=CC(=O)C3=C(O2)C(=CC=C3)C4=CC=CC=C4.Cl

Safety Information

Storage Condition

Freezer -20℃

References

Target Class Profiling of Small-Molecule Methyltransferases

Publication Name: ACS Chemical Biology

Publication Date: 2023-03-28

DOI: 10.1021/acschembio.3c00124

PI3K/AKT/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors

Publication Name: Medical oncology (Northwood, London, England)

Publication Date: 2023-03-19

DOI: 10.1007/s12032-023-01984-0

Analysis of the Role of PI3K/Akt Pathway in the Realization of the Normalizing Effect of Low-Molecular-Weight Mimetics of NGF and BDNF on Activity of Prooxidant and Antioxidant Systems in C57BL/6 Mice with Modeled Diabetes

Publication Name: Bulletin of Experimental Biology and Medicine

Publication Date: 2022-12

DOI: 10.1007/s10517-023-05688-3

Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats

Publication Name: Inflammopharmacology

Publication Date: 2022-07-25

DOI: 10.1007/s10787-022-01031-w

RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes

Publication Name: Basic Research in Cardiology

Publication Date: 2022-03-01

DOI: 10.1007/s00395-022-00915-w

LY-294,002 hydrochloride, 98%, selective inhibitor of PI 3-kinase

Product Information

General Information

Safety Information

References

Target Class Profiling of Small-Molecule Methyltransferases

PI3K/AKT/mTOR inhibitors as potential extracellular matrix modulators for targeting EMT subtype gastric tumors

Analysis of the Role of PI3K/Akt Pathway in the Realization of the Normalizing Effect of Low-Molecular-Weight Mimetics of NGF and BDNF on Activity of Prooxidant and Antioxidant Systems in C57BL/6 Mice with Modeled Diabetes

Role of the NRG1/ErbB4 and PI3K/AKT/mTOR signaling pathways in the anti-psychotic effects of aripiprazole and sertindole in ketamine-induced schizophrenia-like behaviors in rats

RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes